Skip to main content
. 2007 Oct 30;4(5):267–277. doi: 10.7150/ijms.4.267

Figure 3.

Figure 3

Comparison of cells transfected with LipofectAmin or treated with BioShuttle and control cells. The upper row shows the CLSM Images of the untreated HeLa control cells. A distinct fluorescence signal is not detectable. The middle row exhibits the partial high fluorescence intensity of the LipofectAmin® transfected cells whereas the predominant part of the cells a low fluorescence signal located near the cellular membrane (right). The DIC-exposure (left) shows apoptotic features like Membrane blebbing. The lower row exemplifies the fluorescence signals in HeLa cells after BioShuttle phNIS-IRES-EGFP-transport. In all HeLa cells a nearly homogeneous fluorescence signal could be observed as revealed by merged in the DIC- and fluorescence exposures.